Health MBP134 and Remdesivir Trial: Evaluating Safety and Effectiveness by Dr Natalie Singh - Health Editor July 6, 2026 by Dr Natalie Singh - Health Editor July 6, 2026 The National Institutes of Health (NIH) is conducting the ACTIV-3 clinical trial to evaluate the safety and efficacy of the monoclonal antibody MBP134 alongside the antiviral drug remdesivir in hospitalized … 0 FacebookTwitterPinterestEmail